RecallDepth
Class I Terminated

ADRUCIL (fluorouracil injection, USP), 5 g/100 mL (50 mg/mL) glass vials, 5 x 100 ml vials per carton, manufactured by Teva Parenteral Medicines, Inc., Irvine, CA. NDC 073-3019-11 (individual vial), NDC 0703-3019-12 (carton of five).

Company
Teva Pharmaceuticals Usa
Recall Initiated
July 24, 2015
Posted
September 2, 2015
Recall Number
D-1351-2015
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
6001 vials
Firm Location
Horsham, PA, United States

Reason for Recall

Presence of Particulate Matter: silcone rubber and fluorouracil crystals found floating in solution

Distribution

Nationwide.

Lot / Code Info

Lot # 31317857B, Exp 08/15 31317859B, Exp 12/15 31317920B, Exp 12/15 31317957B, Exp 12/15 31318136B, Exp 12/15 31318138B, Exp 12/15

More recalls by Teva Pharmaceuticals Usa

View all recalls by this company →

Other recent Class I Drug recalls